Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab.
Ideguchi
H
H
Ohno
S
S
Takase
K
K
Hattori
H
H
Kirino
Y
Y
Takeno
M
M
Ishigatsubo
Y
Y
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D051359:Lymphohistiocytosis, Hemophagocytic / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab